Progressive loss of estrogen receptor α cofactor recruitment in endocrine resistance

Molecular Endocrinology

Volumn 21, Issue 11, 2007, Pages 2615-2626

  Naughton, Catherine ^a   MacLeod, Kenneth ^a   Kuske, Barbara ^a   Clarke, Robert ^b   Cameron, David A ^a,c   Langdon, Simon P ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b GEORGETOWN UNIVERSITY   (United States)

^c Northern and Yorkshire Clinical Trials and Research Unit   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA; RNA;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CANCER MODEL; CANCER RESISTANCE; CELL STRAIN MCF 7; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ESTROGEN ACTIVITY; GENE DISRUPTION; GENE INDUCTION; HUMAN; HUMAN CELL; IN VIVO CULTURE; PRIORITY JOURNAL; RECEPTOR GENE; RNA INTERFERENCE; TRANSCRIPTION REGULATION;

BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; ENDOCRINE SYSTEM; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR MODULATORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PROMOTER REGIONS (GENETICS); PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA INTERFERENCE; RNA, MESSENGER; TIME FACTORS;

EID: 35648967576     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2007-0110     Document Type: Article

References (38)

1. Ali S, Coombes RC 2002 Endocrine-responsive breast cancer and strategies for combating resistance. Nat Rev Cancer 2:101-112
2. Normanno N, Di Maio M, De Maio E, De Luca A, de Matteis A, Giordano A, Perrone F 2005 Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer. Endocr Relat Cancer 12:721-747
3. Danielian PS, White R, Lees JA, Parker MG 1992 Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J 11:1025-1033
4. Parker MG 1995 Structure and function of estrogen receptors. Vitam Horm 51:267-87
5. Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, Agard DA, Greene GL 1998 The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95:927-937
6. Brownell JE, Allis CD 1996 Special HATs for special occasions: linking histone acetylation to chromatin assembly and gene activation. Curr Opin Genet Dev 6:176-184
7. Belandia B, Parker MG 2003 Nuclear receptors: a rendez-vous for chromatin remodeling factors. Cell 114:277-280
8. Xu J, Li Q 2003 Review of the in vivo functions of the p160 steroid receptor coactivator family. Mol Endocrinol 17:168116-92
9. Shang Y, Hu X, DiRenzo J, Lazar MA, Brown M 2000 Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103:843-852
10. Métivier R, Penot G, Hübne MR, Reid G, Brand H, Koš M, Gannon F 2003 Estrogen receptor-α directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115:751-763
11. Cavarretta ITR, Mukopadhyay R, Lonard DM, Cowsert LM, Bennett CF, O'Malley BW, Smith CL 2002 Reduction of coactivator expression by antisense oligodeoxynucleotides inhibits ERα transcriptional activity and MCF-7 proliferation. Mol Endocrinol 16:253-270
12. Torres-Arzayus MI, Font de Mora J, Yuan J, Vazquez F, Bronson R, Rue M, Sellers WR, Brown M 2004 High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene. Cancer Cell 6:263-274
13. Bautista S, Valles H, Walker RL, Anzick S, Zeillinger R, Meltzer P, Theillet C 1998 In breast cancer, amplification of the steroid receptor coactivator gene AIB1 is correlated with estrogen and progesterone receptor positivity. Clin Can Res 4:2925-2929
14. Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, Guan X, Sauter G, Kallioniemi O, Trent JM, Meltzer PS 1997 AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277:965-968
15. Osborne CK, Bardou B, Hopp TA, Chamness GC, Hilsenbeck SG, Fuqua SAW, Wong J, Allred DC, Clark GM, Schiff R 2003 Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer. J Natl Cancer Inst 95:353-361
16. Heinzel T, Lavinsky RM, Mullen TM, Soderstrom M, Laherty CD, Torchia J, Yang WM, Brard G, Ngo SD, Davie JR, Seto E, Eisenman RN, Rose DW, Glass CK 1997 A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 38:43-48
17. Nagy L, Kao HY, Chakravarti D, Lin RJ, Hassig CA, Ayer DE, Schreiber SL, Evans RM 1997 Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 89:373-380
18. Chen JD, Evans RM 1995 A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377:454-457
19. Lavinsky RM, Jepsen K, Heinzel T, Torchia J, Mullen T, Schiff R, Del-Rio AL, Ricote M, Ngo S, Gemsch J, Hilsenbeck SG, Osborne CK, Glass CK, Rosenfeld MG, Rose DW 1998 Diverse signalling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes. Proc Nat Acad Sci 95:2920-2925
20. Liu X, Bagchi MK 2004 Recruitment of distinct chromatin-modifying complexes by tamoxifen-complexed estrogen receptor at natural target gene promoters in vivo. J Biol Chem 279:15050-15058
21. Prest SJ, May FEB, Westley BR 2002 The estrogen-regulated protein, TFF1, stimulates migration of human breast cancer cells. FASEB J 16:592-594
22. Brunner N, Boulay V, Fojo A, Freter CE, Lippman ME, Clarke R 1993 Acquisition of hormone-independent growth in MCF-7 cells is accompanied by increased expression of estrogen-regulated genes but without detectable DNA amplifications. Cancer Res 53:283-290
23. Brunner N, Boysen B, Jirus S, Skaar TC, Holst-Hansen C, Lippman J, Frandsen T, Spang-Thomsen M, Fuqua AW, Clarke R 1997 MCF7/LCC9: an antiestrogen-resistant variant in which acquired resistance to the steroidal anti-estrogen ICI 182780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen. Cancer Res 57:3486-3493
24. Kuske B, Naughton C, Moore K, MacLeod KG, Miller WR, Clarke R, Langdon SP, Cameron DA 2006 Endocrine therapy resistance can be associated with high estrogen receptor α(ERα) espression and reduced ERα phosphorylation in breast cancer models. Endocrine Related Cancer 13:1121-1133
25. Hong, S, Privalsky ML 2000 The SMRT corepressor is regulated by a MEK-1 kinase pathway: inhibition of corepressor function is associated with SMRT phosphorylation and nuclear export. Mol Cell Biol 20:6612-6625
26. Smith CL, Nawaz Z, O'Malley BW 1997 Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen. Mol Endocrinol 11:657-666
27. Zhang X, Jeyakumar M, Petukhov S, Bagchi MK 1998 A nuclear receptor corepressor modulates transcriptional activity of antagonist-occupied steroid hormone receptor. Mol Endocrinol 12:513-524
28. Fujita T, Kobayashi Y, Wada O, Tateishi Y, Kitada L, Yamamoto Y, Takashima H, Murayama A, Yano T, Baba T, Kato S, Kawabe Y, Yanagisawa J 2003 Full activation of estrogen receptor α activation function-1 induces proliferation of breast cancer cells. J Biol Chem 278:26704-26714
29. McKenna NJ, O'Malley BW 2002 Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108:465-474
30. Dutertre M, Smith CL 2003 Ligand-independent interactions of p160/steroid receptor coactivators and CREB-binding protein (CBP) with estrogen receptor-α: regulation by phosphorylation sites in the A/B region depends on other receptor domains. Mol Endocrinol 17:1296-1314
31. Lopez GN, Turck CW, Schaufele F, Stallcup MR, Kushner PJ 2001 Growth factors signal to steroid receptors through mitogen-activated protein kinase regulation of p160 coactivator activity. J Biol Chem 276:22177-22182
32. Rowan B, Weigel N, O'Malley BW 2000 Phosphorylation of steroid receptor coactivator-1. J Biol Chem 275:4475-4483
33. Wu R, Qin J, Yi P, Wong J, Tsai SY, Tsai M, O'Malley BW 2004 Selective phosphorylations of the SRC-3/AIB1 coactivator integrate genomic reponses to multiple cellular signaling pathways. Mol Cell 15:937-949
34. Wu R, Qin J, Hashimoto Y, Wong J, Xu J, Tsai YS, Tsai M, O'Malley BW 2002 Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) coactivator activity by IκB kinase. Mol Cell Biol 22:3549-3561
35. Wu R, Smith CL, O'Malley BW 2005 Transcriptional regulation by steroid receptor coactivator phosphorylation. Endocr Rev 26:393-399
36. Shao W, Krasnickas Keeton E, McDonnell DP, Brown M 2004 Coactivator AIB1 links estrogen receptor transcriptional activity and stability. Proc Natl Acad Sci 101:11599-11604
37. Ciocca DR, Elledge R 2000 Molecular markers for predicting response to tamoxifen in breast cancer patients. Endocrine 13:1-10
38. Mass R 2000 The role of HER-2 expression in predicting response to therapy in breast cancer. Semin Oncol 27:46-52